Talazoparib Dual-targeting on Poly (ADP-ribose) Polymerase-1 and -16 Enzymes Offers a Promising Therapeutic Strategy in Small Cell Lung Cancer Therapy: Insight from Biophysical Computations
2022Cell Biochemistry and BiophysicsJournal
10.1007/s12013-022-01075-3Full text6 citations